Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical ...
Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14-18, 2025 in Boston.
A persistent challenge in biomarker testing is the reliance on formalin-fixed paraffin-embedded (FFPE) tissue samples. FFPE ...
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with ...
The project will generate the first large-scale, telomere-to-telomere quality reference genomes representing the Korean population and integrate the data into the global Human Pangenome Reference ...
Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit ...
Cleared by the FDA in 2024, the test gained real-world traction in 2025 when it was incorporated into a new global framework ...
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Caris Life Sciences, Inc. is one of them ...
Overall growth in revenues, capital, and activity among leading companies reflect the field’s increasing importance as highlighted in this year’s Top 10 Spatial Biology Companies of 2025. The below Up ...
The world’s first vaccine trial against elephant endotheliotropic herpesvirus (EEHV) – a leading cause of death in young Asian elephants – is safe and triggers a strong virus-fighting immune response, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback